Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04753775Completed
Randomised, double-blind trial in ulcerative proctosigmoiditis comparing Aloe Vera + Mesalazine with Placebo + Mesalazine (2 arms). Primary endpoint: Endoscopic Remission at 4 weeks. Started Mar 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04753775.